Immunotherapy: balancing the risks and benefits
Lancet Oncol
.
2024 Feb;25(2):147.
doi: 10.1016/S1470-2045(24)00028-7.
Author
The Lancet Oncology
PMID:
38301683
DOI:
10.1016/S1470-2045(24)00028-7
No abstract available
Publication types
Editorial
MeSH terms
Humans
Immunotherapy* / adverse effects
Risk Assessment